Infectious Diseases News and Research

RSS

Recent releases in Global Health

Ahead of the U.N. Climate Change conference in Copenhagen next week, a Lancet comment examines the health consequences associated with climate change and the case for linking climate and health goals. "The issue now is not whether climate change is occurring, but how we can respond most effectively. ... Responding to climate change is not a distraction from the business of protecting health: it is part of the same agenda," the author writes (Chan, 12/5).

4 Dec 2009

Action on climate change will save lives, according to Canadian health professionals

Canada's prime minister must put the health of the world's citizens at the centre of discussions at the upcoming UN climate summit, according to Canadian health professionals. Prime Minister Stephen Harper announced last week that he will join world leaders at the historic meeting in Copenhagen in December.

4 Dec 2009

Campaign for legislation to protect adult film industry performers

On Friday, a broad coalition of health groups will unveil a campaign to press for California legislation to protect adult film industry performers. The legislative push will be formally announced in conjunction with a strategy symposium for the effort being held Friday, December 4th at UCLA (Public Affairs Building, North Campus).

4 Dec 2009

Habitat destruction and biodiversity loss can increase the incidence of infectious diseases

The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with McDonald's burgers.

4 Dec 2009

Climate change can cause major impact on global mental health

Leading mental health researchers are warning that some of the most important health consequences of climate change will be on mental health, yet this issue is unlikely to be given much attention at the UN climate change conference in Copenhagen next week.

4 Dec 2009

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic.

4 Dec 2009

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

Dr. Julio Montaner - Director, British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and President, International AIDS Society - congratulated Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), for taking a leadership role in the evaluation of the "Seek and Treat" strategy originally developed at the BC-CfE.

3 Dec 2009

Respiratory syncytial virus, the most common cause of pneumonia in children

RSV is a respiratory virus that infects the lungs and breathing passages. While most healthy people recover from RSV infection, it can be severe in infants. According to the United States Centers for Disease Control and Prevention (CDC), RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under 1 year of age in the nation.

3 Dec 2009

Children vaccinated against chickenpox at much lower risk of developing shingles

Vaccination to prevent chickenpox (varicella) appears to have an added benefit for children—a reduced risk of shingles (herpes zoster). That's the finding of a study in the November issue of The Pediatric Infectious Disease Journal, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

3 Dec 2009

Sepsis, a serious infection, remains a major threat to 'late preterm' infants

Sepsis is a serious infection that is a major cause of death in very premature infants. But sepsis is also a threat in "late preterm" infants born just a few weeks prematurely, according to a study in the December issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

3 Dec 2009

International AIDS Vaccine Initiative calls for redoubled efforts in vaccine development

As we approach World AIDS Day, observed globally December 1, we are reminded that while progress has been made in expanding access to treatment and prevention and that progress has been made toward the development of new prevention tools, the world is still falling short of established targets for providing universal access to HIV and AIDS prevention, treatment and care by 2010. Nearly 5.5 million of the estimated 9.5 million people in need of antiretroviral therapy are still not receiving it.

2 Dec 2009

MUHC researchers identify first genetic resistance factor against TB infection

Why do some people who are exposed to tuberculosis not become infected or develop the disease? Dr. Erwin Schurr and his team at the Research Institute from the McGill University Health Centre (RI-MUHC), in collaboration with Dr. Alexandre Alcais, from the Institut national de la sant- et de la recherche m-dicale (INSERM) in Paris, has shed light on this question for the first time. Their

2 Dec 2009

CRO to run CEL-SCI's upcoming Phase III clinical trial

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.

1 Dec 2009

Op-eds on World AIDS Day: Research, funding, hunger, Uganda

The "National Institutes of Health - perhaps our best hope for funding a cure for AIDS - has been underfunded since 2003," Kate Krauss, director of the AIDS Policy Project, writes in a Philadelphia Inquirer opinion piece.

1 Dec 2009

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

TriCore Reference Laboratories of Albuquerque, N.M., reported at a recent user meeting results of their research collaboration with Roche Applied Science in which they evaluated Roche´s new MagNA Pure 96 System for use in nucleic acid purification. The evaluation focused on the Roche system’s ability to process specimens for pathogen testing.

1 Dec 2009

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Akonni Biosystems, a molecular diagnostics (MDx) company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced receipt of a $3.2M Phase II SBIR grant from the National Institutes of Health (NIH).

1 Dec 2009

Centura Health establishes comprehensive trauma system across its regional facilities

According to the Colorado Department of Public Health and Environment, trauma is the leading cause of death for Coloradans ages one to 44. Studies indicate that 30 to 40 percent of all trauma deaths occur within one hour of injury, and that 30 to 40 percent of these deaths are preventable if timely, appropriate care is received.

1 Dec 2009

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the Company has finalized a "Patent License Agreement with Los Alamos National Security."

30 Nov 2009

Tripep completes phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio’s electroporation technology.

30 Nov 2009

WHITIA launches digital medical X-ray device for screening infectious diseases in developing countries

The World Health Imaging, Telemedicine and Informatics Alliance (WHITIA) today unveiled Remi-d, a new product concept that is intended to provide remote-operated X-ray capabilities for use in screening across areas of the developing world experiencing the Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) co-epidemic, high incidences of Black Lung disease, or outbreaks of other infectious respiratory diseases.

30 Nov 2009

Infectious Diseases News and Research

Recent releases in Global Health

Action on climate change will save lives, according to Canadian health professionals

Campaign for legislation to protect adult film industry performers

Habitat destruction and biodiversity loss can increase the incidence of infectious diseases

Climate change can cause major impact on global mental health

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

Respiratory syncytial virus, the most common cause of pneumonia in children

Children vaccinated against chickenpox at much lower risk of developing shingles

Sepsis, a serious infection, remains a major threat to 'late preterm' infants

International AIDS Vaccine Initiative calls for redoubled efforts in vaccine development

MUHC researchers identify first genetic resistance factor against TB infection

CRO to run CEL-SCI's upcoming Phase III clinical trial

Op-eds on World AIDS Day: Research, funding, hunger, Uganda

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Centura Health establishes comprehensive trauma system across its regional facilities

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Tripep completes phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine

WHITIA launches digital medical X-ray device for screening infectious diseases in developing countries

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News